Electrical Impedance Tomography-Derived Flow Index for Predicting Weaning Success and Post-Extubation Outcomes: A Multicenter Prospective Observational Study
NCT ID: NCT06876792
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2023-09-01
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Electrical Impedance Tomography to Investigate the Relationship Between Airflow Rate During High-flow Oxygen Therapy and Pressure in Patients With Heart Failure Compared to Non-invasive Ventilation
NCT06107907
Effect of Different VV ECMO Flows on Lung Perfusion Monitored by EIT
NCT05778292
Effects of Inspiratory vs Expiratory Breath-Hold on Lung Perfusion Measured by EIT Saline Indicator Method: A Self-Controlled Study
NCT07303972
New Saline-contrast EIT Method Without Breath Hold by Low Pass Filter
NCT07081295
Electrical Impedance Tomography for Quantification of Pulmonary Edema in Acute Respiratory Distress Syndrome Patients
NCT02870894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
≥48 hours and met standard criteria for SBT readiness underwent a standardized 30-minute pressure-support SBT (PSV 8 cmH₂O, PEEP 5 cmH₂O, FiO₂ ≤0.5). Continuous EIT recordings were performed to calculate global and regional FI from pixel-level inspiratory flow-time curves. Pendelluft magnitude was quantified as the percentage of intrapulmonary gas redistribution during inspiration. Conventional indices (RSBI, MIP, P0.1, NIF) and physiological variables were recorded. Primary Endpoint: SBT success (completion without respiratory distress, desaturation, or hemodynamic instability).
Secondary Endpoints:
* Reintubation within 48 h
* Weaning failure
* Ventilator-free days at day 7
* ICU mortality Predictive accuracy was evaluated via ROC analysis in training (n=90) and validation (n=60) cohorts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional method Respiratory Drive group
Conventional method Respiratory Drive group(Methods include: esophageal pressure monitoring, airway obstruction pressure (P0.1) )
electrical impedance tomography
Respiratory drive assessed by flow index measured by electrical impedance tomography.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electrical impedance tomography
Respiratory drive assessed by flow index measured by electrical impedance tomography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute respiratory failure requiring intubation and mechanical ventilation ≥48 hours
* Hemodynamic stability (no escalation of vasoactive agents)
* Oxygenation: FiO₂ ≤0.5, PEEP ≤8 cmH₂O
* Meeting standard ICU criteria for SBT readiness
Exclusion Criteria
* High cervical spinal cord injury
* Deep sedation (RASS ≤-3)
* Inadequate EIT signal quality
* Contraindications to EIT (e.g., implanted cardiac devices)
* Pregnancy
* Expected survival \<24 h
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Rui Jin Hospital
UNKNOWN
Foshan Hospital of Traditional Chinese Medicine
OTHER
Fujian Provincial Hospital
OTHER
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongping Qu
Role: STUDY_CHAIR
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Jialin Liu
Role: STUDY_DIRECTOR
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
rui zhang
Role: PRINCIPAL_INVESTIGATOR
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Fujian Provincial Hospital
Fuzhou, Fujian, China
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202530
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.